Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy

Background: Morus alba Linn, referred to as white mulberry, is a potential traditional medicine for diabetes and neuroprotection. Aim: Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy. Material and methods: The stem Bark of M. alba...

Full description

Bibliographic Details
Main Authors: Rashmi Pathak, Neetu Sachan, Atul Kabra, Ashwag S. Alanazi, Mohammed M. Alanazi, Nawaf A. Alsaif, Phool Chandra
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Saudi Pharmaceutical Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016423001792
_version_ 1797754024925069312
author Rashmi Pathak
Neetu Sachan
Atul Kabra
Ashwag S. Alanazi
Mohammed M. Alanazi
Nawaf A. Alsaif
Phool Chandra
author_facet Rashmi Pathak
Neetu Sachan
Atul Kabra
Ashwag S. Alanazi
Mohammed M. Alanazi
Nawaf A. Alsaif
Phool Chandra
author_sort Rashmi Pathak
collection DOAJ
description Background: Morus alba Linn, referred to as white mulberry, is a potential traditional medicine for diabetes and neuroprotection. Aim: Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy. Material and methods: The stem Bark of M. alba was peeled and subjected to extraction. A phytoconstituent was then isolated by column chromatography and characterized using Mass spectroscopy, FTIR, and NMR. The isolated phytoconstituent was used to formulate a nanoemulsion. Nanoemulsion was also characterized for viscosity, surface tension, refractive index, pH, and particle size. Selected nanoemulsion formulations were then tested for acute oral toxicity and diabetic neuropathy, including behavioral, hematological, histopathological, and biomarker examinations. Results: The spectral analysis affirmed that the isolated compound was found to be chrysin. A nanoemulsion formulation was made using the chrysin and was characterized and found to be stable during the stability testing and fulfilled all other testing parameters. Then acute oral toxicity study of the formulations was found to be safe. Formulations were found to possess significant results against diabetic neuropathy in rats. Biomarkers were analyzed for their mechanistic involvement in reducing neuropathy in rats, and it was found that the oxidative pathway was considerably restored, suggesting that chrysin causes these effects via this pathway. Conclusions: Results suggests that isolated phytoconstituent (chrysin) from the bark of Morus alba derived nanoemulsion has protective and beneficial effects by diminishing the oxidative damage against alloxan-induced diabetic neuropathy in rats.
first_indexed 2024-03-12T17:27:27Z
format Article
id doaj.art-62e1c830cf464ce9ae36f116092f64be
institution Directory Open Access Journal
issn 1319-0164
language English
last_indexed 2024-03-12T17:27:27Z
publishDate 2023-08-01
publisher Elsevier
record_format Article
series Saudi Pharmaceutical Journal
spelling doaj.art-62e1c830cf464ce9ae36f116092f64be2023-08-05T05:15:17ZengElsevierSaudi Pharmaceutical Journal1319-01642023-08-01318101687Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathyRashmi Pathak0Neetu Sachan1Atul Kabra2Ashwag S. Alanazi3Mohammed M. Alanazi4Nawaf A. Alsaif5Phool Chandra6Department of Pharmacy, Invertis University, Bareilly-243123, Uttar Pradesh, IndiaMaharana Pratap College of Pharmacy, Mandhana, Kanpur-209217, Uttar Pradesh, IndiaUniversity Institute of Pharma Sciences, Chandigarh University, Gharuan, 140301 Mohali, Punjab, IndiaDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh aadea, Saudi ArabiaDepartment of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh aadea, Saudi ArabiaTeerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad-244001, Uttar Pradesh, India; Corresponding author.Background: Morus alba Linn, referred to as white mulberry, is a potential traditional medicine for diabetes and neuroprotection. Aim: Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy. Material and methods: The stem Bark of M. alba was peeled and subjected to extraction. A phytoconstituent was then isolated by column chromatography and characterized using Mass spectroscopy, FTIR, and NMR. The isolated phytoconstituent was used to formulate a nanoemulsion. Nanoemulsion was also characterized for viscosity, surface tension, refractive index, pH, and particle size. Selected nanoemulsion formulations were then tested for acute oral toxicity and diabetic neuropathy, including behavioral, hematological, histopathological, and biomarker examinations. Results: The spectral analysis affirmed that the isolated compound was found to be chrysin. A nanoemulsion formulation was made using the chrysin and was characterized and found to be stable during the stability testing and fulfilled all other testing parameters. Then acute oral toxicity study of the formulations was found to be safe. Formulations were found to possess significant results against diabetic neuropathy in rats. Biomarkers were analyzed for their mechanistic involvement in reducing neuropathy in rats, and it was found that the oxidative pathway was considerably restored, suggesting that chrysin causes these effects via this pathway. Conclusions: Results suggests that isolated phytoconstituent (chrysin) from the bark of Morus alba derived nanoemulsion has protective and beneficial effects by diminishing the oxidative damage against alloxan-induced diabetic neuropathy in rats.http://www.sciencedirect.com/science/article/pii/S1319016423001792Morus albaIsolationChrysinNanoemulsionDiabetic Neuropathy
spellingShingle Rashmi Pathak
Neetu Sachan
Atul Kabra
Ashwag S. Alanazi
Mohammed M. Alanazi
Nawaf A. Alsaif
Phool Chandra
Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
Saudi Pharmaceutical Journal
Morus alba
Isolation
Chrysin
Nanoemulsion
Diabetic Neuropathy
title Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
title_full Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
title_fullStr Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
title_full_unstemmed Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
title_short Isolation, characterization, development and evaluation of phytoconstituent based formulation for diabetic neuropathy
title_sort isolation characterization development and evaluation of phytoconstituent based formulation for diabetic neuropathy
topic Morus alba
Isolation
Chrysin
Nanoemulsion
Diabetic Neuropathy
url http://www.sciencedirect.com/science/article/pii/S1319016423001792
work_keys_str_mv AT rashmipathak isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT neetusachan isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT atulkabra isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT ashwagsalanazi isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT mohammedmalanazi isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT nawafaalsaif isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy
AT phoolchandra isolationcharacterizationdevelopmentandevaluationofphytoconstituentbasedformulationfordiabeticneuropathy